MedPath

Efficacy and safety of Anti-reflux mucosal ablation for refractory GERD: Multi-center prospective study.

Not Applicable
Recruiting
Conditions
PPI/PCAB refractory/dependent GERD
Registration Number
JPRN-UMIN000045188
Lead Sponsor
Showa University Koto Toyosu Hospital, Digestive Diseases Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

Inability or unwillingness of patients to give written informed consent. Patient with prominent sliding hernia. Patient with impaired esophageal motility. Pregnancy. Patient with psychiatric/Neurological disorders. Patient with severe comorbidities. Judged unsuitable for this study by the physicians

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath